Herbs as medicines

Archives of Internal Medicine

Volumn 158, Issue 20, 1998, Pages 2192-2199

  Winslow, Lisa Corbin ^a,b   Kroll, David J ^c  

^a HealthOne   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACTYLODES EXTRACT; HERBACEOUS AGENT; NUTMEG OIL; PAEONIA EXTRACT; PLANT EXTRACT; PROPOLIS; SALVIA OFFICINALIS EXTRACT; STRAMONIUM; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANGELICA SINENSIS; CARDIOTOXICITY; COMFREY; CULTURAL FACTOR; DANDELION; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG LEGISLATION; DRUG SAFETY; ECHINACEA; EVIDENCE BASED MEDICINE; GARLIC; GINSENG; GLYCYRRHIZA; HEALTH ECONOMICS; HEALTH INSURANCE; HERB; HERBAL MEDICINE; HUMAN; MEDICAL PRACTICE; NEPHROTOXICITY; NEUROTOXICITY; PATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; TEA; VISCUM ALBUM;

ANGIOSPERMS; DRUG COSTS; HUMANS; PHYTOTHERAPY; UNITED STATES;

EID: 0032501113     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.20.2192     Document Type: Review

References (70)

1. Herbal roulette. Consumer Reports. November 1995:698-705.
2. The American College Dictionary. New York, NY: Random House Inc; 1957:565.
3. Kleiner SM. The true nature of herbs. Phys Sports Med. 1995;23:13-14.
4. Akerele O. Nature's medicinal bounty: don't throw it away. World Health Forum. 1993;14:390-395.
5. Trevelyan J. Herbal medicine. Nurs Times. 1993; 89:36-38.
6. Aliotta G, Capasso G, Pollio A, Strumia S, De Santo NG. Early contributors to nephrology: Joseph Jacob Plenck. Am J Nephrol. 1994;14:377-382.
7. Frate DA, Croom EM, Frate JB, Juergens JB. Self-treatment with herbal and other plant-derived remedies: rural Mississippi, 1993. MMWR Morb Mortal Wkly Rep. 1995;44:204-207.
8. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. N Engl J Med. 1993; 328:246-252.
9. Brown JS, Marcy SA. The use of botanicals for health purposes by members of a prepaid health plan. Res Nurs Health. 1991;14:339-350.
10. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med. 1991;151: 2281-2288.
11. Ross C. New life for old medicine. Lancet. 1992; 342:486-487.
12. Gesler WM. Therapeutic landscapes: medicinal issues in light of the new cultural geography. Soc Sci Med. 1992;34:735-746.
13. Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA. 1995;273:607-609.
14. Tyler VE. What pharmacists should know about herbal remedies. J Am Pharm Assoc. 1996;36: 29-37.
15. The right stuff: Drug Store News picks the categories taking off in '94. Drug Store News. 1994; 16:15.
16. Phillips LG, Nichols MH, King WD. Herbs and HIV: the health food industry's answer. South Med J. 1995;988:911-913.
17. Whitaker B. Now in the HMO: yoga teachers and naturopaths. New York Times. November 24, 1996:11.
18. Gill GV, Redmond S, Garratt F, Paisey R. Diabetes and alternative medicine: cause for concern. Diabet Med. 1994;11:210-213.
19. Price E. Root digging in the Appalachians: the geography of botanical drugs. Geogr Rev. 1960;50:1-20.
20. Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. Binghampton, NY: Pharmaceutical Products Press; 1994.
21. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London, England: The Pharmaceutical Press; 1996.
22. Saxe T. Toxicity of medicinal herbal preparations. Am Fam Phys. 1987;35:135-142.
23. Siegel R. Kola, ginseng, and mislabeled herbs. JAMA. 1978;237:24.
24. Abt AB, Oh JY, Huntington RA, Burkhart KK. Chinese herbal medicines induced acute renal failure. Arch Intern Med. 1995;155:211-212.
25. DuPont R, Bogema S. Benzodiazapines in a health-catalog product. JAMA. 1990;264:695.
26. Capobianco DJ, Brazis PW, Fox TP. Proximal-muscle weakness induced by herbs. N Engl J Med. 1993;329:1430.
27. The Denver Post. June 13, 1997.
28. Holtan N, Hall S, Knight F, et al. Nonfatal arsenic poisoning in three Hmong patients: Minnesota. MMWR Morb Mortal Wkly Rep. 1984;33:347-349.
29. Levitt C, Paulson D, Duvall K, et al. Folk remedy associated lead poisoning in Hmong children: Minnesota. MMWR Morb Mortal Wkly Rep. 1988;32: 555-556.
30. Smitherman J, Harber P. A case of mistaken identity: herbal medicine as a cause of lead toxicity. Am J Ind Med. 1991;20:795-798.
31. Markowitz, SB, Nunez CM, Klitzman S, et al. Lead poisoning due to Hae Ge Fen: the porphyrin content of individual erythrocytes. JAMA. 1994;271: 932-934.
32. Shaw D, House I, Kolev S, Murray V. Should herbal medicines be licensed? BMJ. 1995;11:451-452.
33. Baker D, Brender J, Davis K. Cadmium and lead exposure associated with pharmaceuticals imported from Asia: Texas. MMWR Morb Mortal Wkly Rep. 1989;38:612-614.
34. Yeoh TS, Lee As, Lee HS. Absorption of mercuric sulphide following oral administration in mice. Toxicology. 1986;41:107-111.
35. D'Arcy PF. Adverse reactions and interactions with herbal medicines, I: adverse reactions. Adverse Drug React Toxicol Rev. 1991;10:189-208.
36. Tyler VE. The Honest Herbal. Binghampton, NY: Pharmaceutical Products Press; 1993.
37. Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. New York, NY: Springer-Verlag NY Inc; 1997.
38. Ridker PM. Toxic effects of herbal teas. Arch Environ Health. 1987;42:133-136.
39. Ridker PM. Health hazards of unusual herbal teas. Am Fam Phys. 1989;39:153-156.
40. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatoxicity. Ann Intern Med. 1992;117:129-132.
41. Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing wild Germander: evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterol Clin Biol. 1992;16:916-922.
42. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroerterol. 1990;12:203-206.
43. Clark F, Reed R. Chaparral-induced toxic hepatitis: California and Texas 1992. MMWR Morb Mortal Wkly Rep. 1992;41:812-814.
44. Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med. 1993;23:526.
45. Anderson T, Konracki S, Lyman D, Parkin W. Diarrhea from herbal tea: New York, Pennsylvania. MMWR Morb Mortal Wkly Rep. 1978;27:248-249.
46. Makheja A, Vanderhoek J, Martyn B. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. Lancet. 1979;1:781.
47. Siegal RK. Ginseng abuse syndrome. JAMA. 1979; 241:1614-1615.
48. Perrotta DM, Coody G, Culmo C. Adverse events associated with ephedrine-containing products: Texas, December 1993-September 1995. JAMA. 1996;276:1711-1712.
49. Knight TE, Hausen BM. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol. 1994;30:423-427.
50. Itami N, Yamamoto K, Andoh T, Akutsu Y. Herbal medicine can induce hypertension. Nephron. 1991; 59:339-340.
51. Liu G. Pharmacological actions and clinical use of Fructus Shizandrae. Chin Med J. 1989;102: 740-749.
52. Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T. Flavonoids, potent inhibitors of the human form phenolsulfotransferase: potential role in drug metabolism and chemoprevention. Drug Metab Dispos. 1996;24:232-237.
53. Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T. Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17-beta-estradiol. Eur J Drug Metab Pharmacokinet. 1995;20:219-224.
54. Cassileth BR. The social implications for questionable cancer therapies. Cancer. 1989;63:1247-1250.
55. Brevoort P. The US botanical market: an overview. HerbalGram. 1996;36:49-57.
56. Houghton PJ. Valerian. Pharm J. 1994;253:95-96.
57. LeBars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind randomized trial of an extract Ginkgo biloba for dementia. JAMA. 1997;278:1327-1332.
58. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol. 1997;54:1-8.
59. Bach D, Schmitt M, Ebeling L. Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH). Phytomedicine. 1997;4:309-313.
60. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313:253-258.
61. Bauer VR, Jurcic K, Puhlmann J, Wagner H. Immunologic in vivo and in vitro studies on Echinacea extracts. Arzneimittelforschung. 1988;38:276-281.
62. Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet. 1982;1:655-657.
63. Stewart JJ, Wood MJ, Wood CD, Mims ME. Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology. 1991;42: 111-120.
64. Knight DW. Feverfew: chemistry and biological activity. Natl Prod Rep. 1995;12:271-276.
65. Cavadas C, Araujo I, Cotrim MD, et al. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABA-A receptor in rat brain. Arzneimittelforschung. 1995;45:753-755.
66. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a garlic preparation vs benzfibrate. Arzneimittelforschung. 1992; 42:1473-1477.
67. Miller S. A natural mood booster. Newsweek. May 5, 1997:74-75.
68. Duran N, Song PS. Hypericin and its photodynamic action. Photochem Photobiol. 1986;43: 677-680.
69. Sultan C, Terraza A, Devillier C, et al. Inhibition of androgen metabolism and binding by a liposterolic extract of Serenoa repens B in human foreskin fibroblasts. J Steroid Biochem Mol Biol. 1984; 20:515-519.
70. Kessler DA. Introducing MEDWATCH: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993; 269:2765-2768.